Martin Hutchings, MD PhD1*, Abraham Avigdor, MD2, Anna Maria Sureda Balari, MD, PhD3, Maria José Terol, MD, PhD4*, Francesc Bosch, MD PhD5*, Paolo Corradini, MD6, Thomas S. Larsen7*, Antonio Rueda Dominguez, MD8*, Alan Skarbnik, MD9, Judit Mészáros Joergensen, MD, PhD10*, David Lavie11*, Ronit Gurion, MD12*, Pier Luigi Zinzani, MD, PhD13, Antonio Pinto, MD14*, Raul Cordoba, MD, PhD15, Alessia Bottos, PhD16*, Donghang Li, PhD17*, James Relf, MD18*, Audrey Filézac De L'Étang, PhD16*, Gila Sellam, PhD16* and Giuseppe Gritti19*
1Rigshospitalet, Copenhagen, Denmark
2Sheba Medical Center, Ramat Gan and Tel Aviv University, Tel Aviv, Israel
3Universitat de Barcelona, Barcelona, Spain
4Hospital Clínico Universitario INCLIVA, University of Valencia, Valencia, Spain
5University Hospital Vall d'Hebron, Barcelona, Spain
6Hematology, University of Milan and Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy
7Odense University Hospital, Odense, Denmark
8Regional and Virgen de la Victoria University Hospitals, Málaga, Spain
9Novant Health Cancer Institute, Lymphoma and CLL Program, Charlotte, NC
10Department of Hematology, Aarhus University Hospital, Aarhus, Denmark
11Hadassah Medical Center, Jerusalem, Israel
12Rabin Medical Center, Petach Tikva and Tel Aviv University, Tel Aviv, Israel
13University of Bologna, Bologna, Italy
14National Cancer Institute Fondazione G. Pascale IRCCS, Naples, Italy
15Fundación Jiménez Díaz University Hospital, Madrid, Spain
16F. Hoffmann-La Roche Ltd, Basel, Switzerland
17F. Hoffmann-La Roche Ltd, Shanghai, China
18Roche Products Ltd, Welwyn Garden City, United Kingdom
19Department of Oncology-Hematology, Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy